The Role and Mechanism of S1PR5 in Colon Cancer

por Zhou, Huijun, Yin, Xianli, Bai, Fei, Liu, Wu, Jiang, Shaofeng, Zhao, Jinfeng
Publicado 2020

Development and validation of a prognostic nomogram for predicting early recurrence after curative resection of stage II/III gastric cancer

por Ma, Min, Xiao, Haifan, Li, Liang, Yin, Xianli, Zhou, Huijun, Quan, Hu, Ouyang, Yongzhong, Huang, Gang, Li, Xiaorong, Xiao, Hua
Publicado 2019

Effect of Reduced-Dose Capecitabine Plus Cetuximab as Maintenance Therapy for RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Clinical Trial

por Wang, Lu, Liu, Ying, Yin, Xianli, Fang, Weijia, Xiong, Jianping, Zhao, Ben, Zhang, Mingsheng, Zou, Yanmei, Qiu, Hong, Yuan, Xianglin
Publicado 2020

Immune checkpoint inhibitors-associated cardiotoxicity in immunotherapy trials on gastrointestinal cancer patients

por Li, Yiqun, Wang, Yanfeng, Li, Ning, Liang, Xinjun, Zhang, Shu, Fan, Qingxia, Yin, Xianli, Zhuang, Zhixiang, Liu, Yunpeng, Zhang, Jingdong, Kou, Xiaoge, Zhong, Haijun, Xu, Binghe, Huang, Jing
Publicado 2022

The relationship between miR-302b and EphA2 and their clinical significance in gastric cancer

por Tang, Lanhua, Hu, Huabin, He, Yijing, Mcleod, Howard L., Xiao, Desheng, Chen, Pan, Shen, Liangfang, Zeng, Shan, Yin, Xianli, Ge, Jie, Li, Li, Ma, Jian, Chen, Zihua, Huang, Jin
Publicado 2018

HX008, an anti-PD1 antibody, plus irinotecan as second-line treatment for advanced gastric or gastroesophageal junction cancer: a multicenter, single-arm phase II trial

por Song, Yan, Li, Ning, Li, Qun, Liang, Xinjun, Zhang, Shu, Fan, Qingxia, Yin, Xianli, Zhuang, Zhixiang, Liu, Yunpeng, Zhang, Jingdong, Kou, Xiaoge, Zhong, Haijun, Wang, Xiaofei, Dou, Yiwei, Huang, Jing
Publicado 2020

miR-302b inhibits tumorigenesis by targeting EphA2 via Wnt/ β-catenin/EMT signaling cascade in gastric cancer

por Huang, Jin, He, Yijing, Mcleod, Howard L., Xie, Yanchun, Xiao, Desheng, Hu, Huabin, Chen, Pan, Shen, Liangfang, Zeng, Shan, Yin, Xianli, Ge, Jie, Li, Li, Tang, Lanhua, Ma, Jian, Chen, Zihua
Publicado 2017

Efficacy, Safety, and Immunogenicity of HLX04 Versus Reference Bevacizumab in Combination with XELOX or mFOLFOX6 as First-Line Treatment for Metastatic Colorectal Cancer: Results o...

por Qin, Shukui, Li, Jin, Bai, Yuxian, Shu, Yongqian, Li, Wei, Yin, Xianli, Cheng, Ying, Sun, Guoping, Deng, Yanhong, Zhong, Haijun, Li, Yunfeng, Qian, Xiaoping, Zhang, Liangming, Zhang, Jingdong, Chen, Kehe, Kang, Wenying
Publicado 2021

Bifunctional anti-PD-L1/TGF-βRII agent SHR-1701 in advanced solid tumors: a dose-escalation, dose-expansion, and clinical-expansion phase 1 trial

por Liu, Dan, Zhou, Jun, Wang, Yongsheng, Li, Mingjun, Jiang, Haiping, Liu, Yunpeng, Yin, Xianli, Ge, Minghua, Xiang, Xiaojun, Ying, Jieer, Huang, Jian, Zhang, Yan-qiao, Cheng, Ying, Huang, Zhigang, Yuan, Xianglin, Han, Weiqing, Yan, Dong, Wang, Xinshuai, Liu, Pan, Wang, Linna, Zhang, Xiaojing, Luo, Suxia, Liu, Tianshu, Shen, Lin
Publicado 2022

Development and external validation of a novel nomogram for screening Chinese Lynch syndrome: based on a multicenter, population study

por Yang, Mengyuan, Li, Dan, Jiang, Wu, Zhu, Lizhen, Ju, Haixing, Sun, Yan, Shan, Yuqiang, Yang, Chunkang, Dong, Jian, Wang, Lin, Wu, Baoping, Qiu, Meng, Yin, Xianli, Wang, Xicheng, Xiong, Bin, Yan, Wei, Liu, Tao, Liu, Chenglin, Mao, Xinru, Ding, Kefeng, Zhang, Suzhan, Zheng, Shu, Xu, Dong, Ding, Peirong, Yuan, Ying
Publicado 2021